JFB Construction CFO Invests $30,000 in Company Stock
Lantana, Fla., December 10, 2025 (GLOBE NEWSWIRE) - JFB Construction Holdings (Nasdaq: JFB), a leader in real estate development and construction, has announced a significant stock purchase by its Chief Financial Officer. On December 9, 2025, Ruben Calderon acquired 1,550 shares of JFB's common stock at an average price of $18.72, totaling approximately $30,000. This move underscores Calderon's confidence in the company’s future prospects.
CFO's Perspective on JFB’s Growth Potential
Ruben Calderon expressed optimism regarding JFB Construction’s strategic direction, stating, “I am confident in JFB Construction’s long-term strategy and the opportunities ahead as we continue to execute on our business plan.” His recent stock purchase reflects a strong belief in the company's financial stability and anticipated growth as the company moves into 2026 and beyond.
Insights into JFB Construction Holdings
JFB Construction Holdings, denoted as JFB, brings decades of experience in residential and commercial construction. The company has a proven track record of executing diverse projects including:
- Multifamily communities
- Shopping centers
- National franchises
- Exclusive estate and equestrian homes
With over 2 million square feet of commercial and retail projects completed, JFB has established a reputation for quality and client satisfaction. Notable is the fact that a significant portion of its business comes from referrals and repeat customers, validating its commitment to delivering outstanding results across 36 U.S. states.
Looking Ahead: Caution on Forward-Looking Statements
Investors should be aware that forward-looking statements reflect the company's expectations and are subject to various risks and uncertainties. The company cautions that actual results may vary significantly from these expectations. Key factors influencing results can be found in the Risk Factors section of JFB's filings with the SEC, accessible at www.sec.gov.
Contact Information
For further inquiries, please contact: